Lung Cancer
Latest News
Could your patient benefit? New trials in lung cancer
A rundown of new clinical trials in lung cancer.
Conference Coverage
Many patients, doctors unaware of advancements in cancer care
“These patients must be spared the traumatic effects of being handed a death sentence that no longer reflects the current reality,” said Dr....
Conference Coverage
Should Geriatric Veterans Get Immunotherapy?
Conference Coverage
Most community-based oncologists skip biomarker testing
Survey shows that 48% of community clinicians use biomarker testing to guide treatment decisions, compared with 73% of academic clinicians.
Latest News
FDA approves first oral drug for NSCLC with EGFR Exon 20 insertion
Mobocertinib is the first oral tyrosine kinase inhibitor for patients with metastatic non–small cell lung cancer who have an EGFR Exon 20...
News
Immunotherapy for cancer patients with poor PS needs a rethink
Patients should not receive immunotherapy just to reduce risk of side effects, doctor says.
Conference Coverage
COVID is especially dangerous for mesothelioma
Case review demonstrates a mortality rate of 57%.
Conference Coverage
Pandemic strategies to boost trial enrollment should stay
Conference Coverage
Air pollution – second leading cause of lung cancer
“As lung cancer professionals, we can mitigate the effects of air pollution on causing lung cancer by speaking out for clean energy standards.”
